BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Diabetes. Oct 15, 2026; 17(10): 117952
Published online Oct 15, 2026. doi: 10.4239/wjd.117952
Toward precision metabolic medicine: Multi-omics deconstruction and translational potential of herbal formulations in glycolipid metabolic disorders
Huo-Xiang Zhou, Wei Guo, Wei-Wei Lin, Fang Xu, Li-Yun Zheng
Huo-Xiang Zhou, Wei Guo, Wei-Wei Lin, Fang Xu, Li-Yun Zheng, Henan Key Laboratory of Health Medicine and Liver Disease Prevention & Treatment, Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, Henan Province, China
Author contributions: Zhou HX and Zheng LY designed, wrote and edited the final manuscript; Guo W, Lin WW and Xu F reviewed and revised the draft of the manuscript. All authors read and approved the final manuscript.
Supported by Key Scientific and Technological Project of Henan Province, No. 252102310044; Natural Science Foundation of Henan, No. 252300423870; and Basic Research Foundation of Henan Institute of Medical and Pharmacological Sciences, No. 2025BP0201.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Corresponding author: Li-Yun Zheng, PhD, Professor, Henan Key Laboratory of Health Medicine and Liver Disease Prevention & Treatment, Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, No. 40 North Daxue Road, Zhengzhou 450052, Henan Province, China. zhengliyun@zzu.edu.cn
Received: December 22, 2025
Revised: January 28, 2026
Accepted: February 25, 2026
Published online: October 15, 2026
Processing time: 284 Days and 13.7 Hours
Abstract

Glycolipid metabolic disorders represent a growing global health burden, characterized by interconnected dysregulations in glucose and lipid metabolism. Traditional Chinese medicine (TCM), broadly accepted as a holistic and multi-target approach, provides promising therapeutic directions for such complex conditions. Recently, Tian et al published a study in World Journal of Diabetes integrated transcriptomic and metabolomic analyses to investigate the mechanisms underlying the ameliorative effects of Jiangtang Tiaozhi formula (JTTZF) on high-fat diet-induced glycolipid dysregulation in mice. The findings revealed that JTTZF modulated key genes involved in lipid synthesis, insulin signaling, and inflammation, and it also restored metabolic pathways for energy production and steroid hormone biosynthesis. This editorial highlights the crucial role of multi-omics methodologies in elucidating the systemic effects of herbal formulations and discusses how such integrative approaches can link TCM with modern precision medicine in the future.

Keywords: Glycolipid metabolism; Traditional Chinese medicine; Herbal formulations; Multi-omics; Precision medicine

Core Tip: Multi-omics technologies are transforming the research paradigm of traditional Chinese medicine (TCM), transitioning it from an experience-based practice to an evidence-based science. The integrated transcriptomic and metabolomic study of the Jiangtang Tiaozhi Formula exemplifies how such approaches can systematically elucidate the “multi-component, multi-target” mechanisms of herbal formulations by revealing the regulation of gene networks and metabolic pathways in complex diseases, such as glycolipid metabolic disorder. Thus, the synergistic integration of traditional knowledge with modern systems biology provides a clear direction for the development of precise, mechanism-driven TCM therapies, promoting their incorporation into contemporary precision medicine.

Write to the Help Desk